TY - JOUR
AU - Mark H. Duncan
AU - Anna D. Ratzliff
AU - Diane M. Powers
AU - Caleb J. Banta-Green
AU - Andrew J. Saxon
A1 - 
AD - University of Washington, Seattle, Washington (M.H.D.).; University of Washington, Advancing Integrated Mental Health Solutions Center, Seattle, Washington (A.D.R., D.M.P.).; University of Washington, Advancing Integrated Mental Health Solutions Center, Seattle, Washington (A.D.R., D.M.P.).; University of Washington, Alcohol and Drug Abuse Institute, Seattle, Washington (C.J.B.).; Veterans Affairs Puget Sound Health Care System and University of Washington, Seattle, Washington (A.J.S.).
BT - Annals of Internal Medicine
C5 - Opioids & Substance Use
CP - 11
CY - United States
DO - 10.7326/L19-0144
IS - 11
JF - Annals of Internal Medicine
LA - eng
M1 - Journal Article
PP - United States
PY - 2019
SN - 1539-3704; 0003-4819
SP - 820
EP - 821
EP - 
T1 - The Next Stage of Buprenorphine Care for Opioid Use Disorder
T2 - Annals of Internal Medicine
TI - The Next Stage of Buprenorphine Care for Opioid Use Disorder
U1 - Opioids & Substance Use
U2 - 31158865
U3 - 10.7326/L19-0144
VL - 170
VO - 1539-3704; 0003-4819
Y1 - 2019
Y2 - Jun 4
ER -